• Input Output CEO claims that his company has no secrets
• Charles Hoskinson is an American software developer and entrepreneur
• Critics claim that Cardano technology is as real as Theranos’s blood tests

During a new ask-me-anything meeting, Input Output CEO Charles Hoskinson said that his organization has no insider facts when requested to say something regarding the Theranos catastrophe.

The Cardano maker asserts that the bombed biotech organization is an incredible illustration of a sorcery box that many needed to work since they required a female Steve Jobs, adding that there is not a glaringly obvious explanation for why a genuine organization would not need the overall population to test its item.

Anybody on the planet can fork Cardano. Anyone on the planet can take our paper and carry out our papers as has been finished by Mina Protocol and Polkadot for a portion of our papers… There’s no limitations. 

Theranos case has blurred the lines between scammers and visionaries

Assuming you are a trick, you don’t allow individuals to see what’s in the background since there’s nothing there. It’s just basic.

The now-dead dear Silicon Valley, which was once esteemed at $9 billion, fell after it unfolded that its Edison blood-testing machines never really worked.

The high-profile Theranos case has obscured the lines among tricksters and visionaries, and organizer Elizabeth Holmes has neglected to persuade the jury with her Svengali protection.

Toward the beginning of January, the previous tycoon was tracked down blameworthy on numerous charges, with her sentencing planned to happen on Sept. 26.

Cardano pundits regularly guarantee that its innovation is just about as genuine as Theranos’ blood tests, blaming the undertaking for being publicity driven vaporware with void guarantees and non-existent clients.

ALSO READ: POLKADOT PARACHAIN FRAUDSTER REVEALED THANKS TO SEC’S COMPLAINT IN 2019

Ambitious crypto companies have to find the right balance

Advertising up items isn’t phenomenal inside the cryptographic money industry, which is by all accounts a lot quicker on overpromising than Silicon Valley. 

The Theranos case shows that aggressive crypto organizations need to track down the right harmony between unnecessary good faith and trustworthiness.

While Holmes’ case probably won’t put a clear finish to the common counterfeit it until you make it’ culture, it could lead toward greater responsibility.

Cardano is one of the greatest blockchains to effectively utilize a proof-of-stake agreement component, which is less energy concentrated than the proof-of-work calculation depended upon by Bitcoin. 

Although a much bigger Ethereum will be moving up to PoS, this progress is simply going to occur step by step.

Cardano supporters have continued to counter criticisms of the blockchain network. Charles Hoskinson, the CEO of IOHK, has said that there is no scenario where Cardano can be compared to the now-folded Theranos. Cardano has “no secrets” unlike the company, he added.

Anyone can verify Cardano’s product, says Hoskinson

Hoskinson commented on a surprise Ask Me Anything (AMA) broadcast he held today.
Weighing in on the high profile case, the chief executive of Cardano’s development arm, stated that Theranos was an example of a company that many wanted to succeed to satisfy their desire for a “female Steve Jobs.”

This is why the biotech company was able to get away with not allowing the public to test its product for so long. In contrast, Hoskinson maintained that Cardano’s work, being open-source, was out there for anyone interested to try out or even personalize. This has been done by Mina Protocol, and to some extent by Polkadot.

 Anyone in the world can fork Cardano…Anyone in the world can take our paper and implement our papers as has been done by Mina Protocol and Polkadot for some of our papers. There’s no restrictions, he said.

He added that this was the major factor that differentiates genuine products from scams. A scam would not let people “see what’s behind the curtain” as there would be nothing there.

That was indeed the case in Theranos. The company and its executives continued to promise investors a revolutionary blood testing kit, the Edison blood-testing machines. Reaching a valuation of over $9 billion at one point, the company went bust after it was revealed that the machine was never going to be delivered.

Last month, Elizabeth Holmes, who was 19 when she founded the company in 2014, was convicted of fraud in federal court.

Cardano’s commendations continue to pile up

Despite critics often calling the Cardano blockchain “vaporware” and a “ghost chain,” the network has been getting commendations too. In a recent report, a 33 person panel of analysts at Finders expressed high optimism for Cardano. The financial comparison site predicted that ADA would reach a price of $2.79 by the end of the year.

Previously, cryptocurrency exchange, Kraken, reported that Cardano’s values-based approach to development would catapult it to becoming one of the top L1 blockchains in the crypto market.

Meanwhile, the price of ADA has taken a hit in the market. ADA is trading at $0.84, down -12.95% from its price 24 hours ago.

News Source

IOHK CEO Charles Hoskinson has come out to defend Cardano from critics who have compared it to the now-defunct biotech startup Theranos.

As part of a surprise ask-me-anything session on Feb. 22, Hoskinson asserted that Cardano is not secretive, unlike Theranos.

Hoskinson: Anyone Can Test Cardano

The tale of Theranos has become quite popular worldwide due to both the brilliance of the founder and its bewildering hype and later collapse. Founded in 2014 by a nineteen-year-old university dropout Elizabeth Holmes, Theranos was lauded for its promises to revolutionize the biomedical sector with a groundbreaking method of blood testing.

It would later turn out that Holmes was very secretive, even prohibiting her employees at Theranos from talking with each other about their activities. Moreover, the whole enterprise was a sham as its vaunted medical devices didn’t work the way Holmes had purported they would.

Hoskinson observed that Theranos is a prime example of a company that many wanted to thrive because they wanted a “female Steve Jobs”. This is the reason why the company was able to stealthily operate for years without letting the general public test its products. He stressed that Cardano, being an open-source project, can be tested by anyone or even adopted by other projects as it has already been done by Mina Protocol and Polkadot.

“Anyone in the world can fork Cardano…Anyone in the world can take our paper and implement our papers as has been done by Mina Protocol and Polkadot for some of our papers. There’s no restrictions,” Hoskinson said. 

The Cardano creator noted that this is a key feature that sets apart a legit company from fraud. A scammy company will not allow people to “see what’s behind the curtain because there’s nothing there”.

After cracks started to show in Theranos’ years-long facade, the United States Securities and Exchange Commission finally charged Holmes with fraud and ordered her to pay a $500,000 fine. In January of this year, a jury found Holmes guilty of defrauding investors of the health-testing startup out of hundreds of millions of dollars.

Cardano’s Barnstorming Growth Is Ignoring The Noise

Since its launch, Cardano has been the subject of criticism from high-profile crypto insiders and investors alike. Such skeptics claim that Cardano’s technology is uncannily like Theranos’ Walgreen blood tests equipment that never worked, further alleging that the crypto project has so many overweening promises and zero users. They have also called Cardano “vaporware” built on intense hype, which is bound to fade away in the future.

Despite the naysayers, Cardano continues to hit milestones after milestones. Just yesterday, ZyCrypto reported that ADA had surpassed the 24-hour transaction volumes of both bitcoin and ethereum for the second time in history. And that’s no small feat.

ADA is changing hands at $0.8658 as of press time, representing a decline of 6.54% over the last 24 hours. Nevertheless, a panel of fintech experts at Finders is optimistic about the token’s future price performance. The panel recently highlighted ADA’s possible run to $2.79 by 2022 year-end.

During a recent ask-me-anything session, Input Output CEO Charles Hoskinson said that his company has “no secrets” when asked to weigh in on the Theranos disaster.

The Cardano creator claims that the failed biotech company is a great example of a “magic box” that many wanted to work because they needed a “female Steve Jobs,” adding that there is no legitimate reason why a real company would not want the general public to test its product:

Anyone in the world can fork Cardano…Anyone in the world can take our paper and implement our papers as has been done by Mina Protocol and Polkadot for some of our papers…There’s no restrictions. If you are a scam, you don’t let people see what’s behind the curtain because there’s nothing there. It’s just that simple.

The now-defunct darling of Silicon Valley, which was once valued at $9 billion, collapsed after it transpired that its Edison blood-testing machines never actually worked.

The high-profile Theranos case has blurred the lines between scammers and visionaries, and founder Elizabeth Holmes has failed to convince the jury with her Svengali defense.

In early January, the former billionaire was found guilty on multiple charges, with her sentencing scheduled to occur on Sept. 26.

Cardano critics often claim that its technology is as real as Theranos’s blood tests, accusing the project of being hype-driven vaporware with empty promises and non-existent users.

Hyping up products is not uncommon within the cryptocurrency industry, which seems to be much keener on overpromising than Silicon Valley. The Theranos case shows that ambitious crypto companies have to find the right balance between excessive optimism and honesty.

While Holmes’s case might not put a definite end to the prevalent “fake it ’til you make it’ culture,” it might lead toward more accountability.